AW
EDSA icon

Avion Wealth’s Edesa Biotech EDSA Stock Holding History

Avion Wealth’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-242
Closed – – 1277
2025
Q1 		$0 Buy
+242
New +$522 ﹤0.01% 1108
2024
Q4 		– Sell
-242
Closed -$1K – 1076
2024
Q3 		$1K Buy
+242
New +$1.1K ﹤0.01% 796

Other funds holding EDSA

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Avion Wealth's EDSA Position: Q2 2025 in Review

Avion Wealth sold out of Edesa Biotech (EDSA) in Q2 2025, closing a stake of 242 shares.

Avion Wealth first reported a position in EDSA in Q3 2024 and held it in 2 quarters. The position peaked at $1K in Q3 2024. 20 funds tracked by Wall St. Rank hold EDSA as of Q2 2025.

  • Avion Wealth reported no remaining Edesa Biotech position as of Q2 2025 after selling out during the quarter.
  • Avion Wealth sold 242 Edesa Biotech shares in Q2 2025.
  • Avion Wealth first reported a position in Edesa Biotech in Q3 2024 and held it in 2 quarters.
  • Avion Wealth's Edesa Biotech position peaked at $1K in Q3 2024.
  • 20 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2025.

Based on Avion Wealth's 13F filing for Q2 2025, filed 25 Jul 2025.